Market Overview
Size, growth, and competitive unit
- Brevintel analysis values the Middle East and Africa medical tourism market at USD 3.2 billion in 2025 ($3.2B).
- The market is expected to grow from USD 3.8 billion in 2026 to USD 9.4 billion in 2035 ($9.4B), at a 10.6% CAGR.
- Revenue expansion from USD 796.4 million in 2022 to USD 3.2 billion in 2025 reflects regional treatment retention rather than a temporary rebound in deferred travel.
- American Hospital Dubai led with over 6.5% market share in 2025.
- The top five—American Hospital Dubai, Cleveland Clinic Abu Dhabi, King Hussein Cancer Center, King Faisal Specialist Hospital and Research Centre, and Mediclinic Middle East—held 22.8% in 2025.
- The relevant competitive unit is a coordinated care corridor: a tertiary hospital, an accredited clinical environment, travel administration, and language-appropriate patient support.
- That configuration is most valuable in cardiac, oncology, fertility, and complex orthopedic cases, where referral friction is costlier than in routine elective procedures.
- Patients travel to regional hubs when specialized treatment is unavailable or delayed at home, while destination providers use accreditation and international-patient coordination to retain patients who might otherwise seek care in Europe, Asia, or North America.
Clinical demand and destination roles
- Noncommunicable diseases account for 74% of deaths in the Middle East and North Africa, with premature mortality from cardiovascular disease, cancer, diabetes, and chronic respiratory disease still above high-income-economy levels.
- Cardiovascular disease cases in North Africa and the Middle East increased substantially between 1990 and 2019, reflecting population growth, aging, and metabolic risk.
- Diabetes prevalence has also risen across MENA, reinforcing the pipeline for cardiovascular and metabolic-disease treatment.
- The UAE, Jordan, Israel, and Saudi Arabia participate differently, from premium tertiary-care hubs to Arabic-language referral centers serving neighboring source markets.
- Brevintel analysis finds the 10.6% growth outlook through 2035 depends on converting clinical capability into a reliable cross-border episode of care.
- Chronic disease expands the treatment pool, but patient flows move when facilities can signal quality, shorten access times, and coordinate admission, payment, companions, and discharge.
- Accreditation and digital patient pathways therefore function as commercial infrastructure, not merely institutional credentials.
Market Dynamics
Demand drivers
- Patients weigh clinical confidence, travel time, language, aftercare, and treatment-access predictability, not headline procedure price alone.
- Jordan's private-hospital sector identifies cardiovascular, bariatric, oncology, orthopedic, and fertility care among procedures demanded by patients from Iraq, Syria, Libya, Yemen, Palestine, and Gulf markets.
- Dubai's circular on hospital accreditation requires licensed private hospitals to obtain accreditation from an ISQua-approved body, placing accreditation in the regulatory baseline for private provision.
- Tertiary providers in the UAE, Jordan, Israel, and Saudi Arabia compete for oncology, transplantation, cardiovascular, maternal-fetal, pediatric, and complex orthopedic referrals.
- International patient departments, clinical translation, referral intake, visa support, and follow-up planning convert specialist capacity into cross-border demand.
- Dubai's medical-tourism positioning has been supported by its Health Experience program and a first-in-MENA, sixth-global ranking in the Medical Tourism Index cited by the Dubai Health Authority.
- Dubai Healthcare City's 2024 legal framework clarifies the free zone's role as an international healthcare and wellness hub.
- Saudi Arabia's Health Sector Transformation Program places healthcare capacity and private-sector participation within Vision 2030, with hospital capacity, specialist provision, and digital-health infrastructure as part of the investment case.
- In Egypt, the Tour 4 Cure platform is intended to digitalize health-tourism access and make participating facilities more visible to international patients.
Constraints and continuity risk
- Cross-border care is hardest to manage after the patient returns home, especially in cardiovascular surgery, oncology, bariatric surgery, transplantation, and revision orthopedics.
- Jordan's private-hospital sector has identified post-operative follow-up as a constraint, especially for patients returning to countries with limited specialist capacity.
- Digital platforms can support referral intake, pre-travel consultation, discharge documentation, and virtual check-ins, but they do not resolve licensing, reimbursement, data-protection, and liability questions.
- Jordan's patient base includes Iraq, Syria, Yemen, Libya, and Palestine, making volumes sensitive to borders, air connectivity, household liquidity, and government treatment funding.
- Israel's ability to serve regional patients is also affected by travel and political conditions, despite the high clinical reputation of its tertiary hospitals.
- Elective cosmetic and dental travel can decline quickly when disposable income, flights, or perceived safety deteriorate, while complex oncology and cardiovascular referrals are more resilient.
- Brevintel analysis indicates post-treatment continuity is the principal quality constraint because it is concentrated in the same high-value treatments that support hospital revenue.
- The market is likely to segment between destinations that can sell a complete episode of care and those that primarily sell access to a procedure.
Segmentation Analysis
Cosmetic and cardiovascular applications
- Cosmetic surgery held the largest application share at 20.4% in 2025 and is projected to expand at a 12.7% CAGR to reach USD 2.3 billion by 2035.
- That 12.7% growth rate exceeds the overall 10.6% market forecast because much of the category can be delivered through specialized outpatient facilities.
- Hair transplantation accounted for approximately 57% of cosmetic-surgery revenue in 2025, followed by breast augmentation at approximately 31% and other procedures at approximately 12%.
- Dubai's premium positioning competes less with high-volume, lower-cost destinations than with facilities targeting patients who weight regulated care, privacy, hospitality, and proximity.
- Cardiovascular surgery generated USD 455.8 million in 2025, with its role defined by clinical complexity rather than procedure volume.
- Diabetes and cardiovascular disease create a persistent referral base, while intensive-care capacity, imaging, interventional expertise, and post-operative monitoring favor accredited tertiary hospitals.
Orthopedic, oncology, and dental applications
- Within orthopedic surgery, knee replacement represented approximately 38.3% of 2025 revenue, followed by hip replacement at 24.5% and spinal procedures at 22.9%.
- Shoulder replacement, ankle replacement, and other orthopedic procedures accounted for the balance, with conversion depending on rehabilitation after the patient returns home.
- Surgical oncology accounted for approximately 35.8% of oncology segment revenue in 2025, followed by radiation therapy at 31.2%, chemotherapy at 24.6%, and other therapies at 8.4%.
- Jordan's King Hussein Cancer Center is a material regional oncology anchor, reinforced by a government program expanding cancer-treatment access for children and older citizens from January 2026.
- Dental surgery generated USD 430.7 million in 2025.
- Implants represented approximately 37.7% of dental revenue, followed by dental cosmetics at 23.8%, orthodontics at 17.9%, prosthetics at 13.7%, and other services at 7.0%.
Other applications and end-use channels
- Bariatric surgery accounted for approximately 11.75% of market revenue in 2025, supported by obesity and metabolic-disease prevalence but dependent on long-term monitoring.
- Fertility treatment accounted for approximately 6.5% of revenue, with demand shaped by assisted-reproduction availability and differing legal and religious requirements.
- Other applications, including neurosurgery, ophthalmology, transplantation, and mental-health care, represented approximately 10.7% of 2025 revenue.
- Specialty clinics generated USD 1.2 billion in 2025, concentrated in cosmetic procedures, dental care, fertility services, and lower-acuity orthopedic interventions.
- Hospitals accounted for 53.3% of market revenue in 2025, equivalent to approximately USD 1.7 billion, reflecting value concentration in cardiovascular, oncology, complex orthopedics, fertility, transplantation, and advanced pediatric services.
- Other end users accounted for approximately 9.2% of 2025 revenue, including rehabilitation providers, medically oriented wellness facilities, and care-coordination platforms.
- Brevintel analysis suggests two commercial models will coexist: throughput-led cosmetic, hair-restoration, and dental care in specialty clinics, versus complexity-led hospital revenue.
- The cosmetic segment's 12.7% CAGR versus 10.6% for the overall market indicates that elective outpatient demand is likely to gain weight in the mix, even as hospitals remain the larger channel at 53.3%.
Regional Outlook
United Arab Emirates
- The UAE was the region's largest country market, generating USD 196.8 million in 2022, USD 362.9 million in 2023, USD 566.4 million in 2024, and USD 780.1 million in 2025.
- Dubai's ecosystem benefits from aviation connectivity, hospitality infrastructure, regulated private care, and a high concentration of internationally recognizable facilities.
- Dubai was ranked first in MENA and sixth globally in the Medical Tourism Index cited by the Dubai Health Authority.
- Compulsory accreditation for licensed private hospitals and the Dubai Healthcare City legal framework reinforce the quality and governance proposition.
- The UAE can target premium elective care as well as complex regional referrals, although its cost base limits direct competition with lower-price destinations.
Jordan and Saudi Arabia
- Jordan generated USD 538.9 million in medical-tourism revenue in 2025 and received more than 235,000 medical tourists.
- The Private Hospitals Association's reported figure of nearly USD 1 billion includes a broader spending base than the market estimate, including related patient and companion expenditure.
- Jordan's private-hospital network, geographic accessibility, Arabic-language service model, and referral links with Iraq, Libya, Syria, Yemen, Palestine, and Gulf markets underpin its position.
- Jordan is strong in oncology, cardiovascular treatment, bariatric surgery, orthopedics, fertility care, and rehabilitation-oriented wellness, including Dead Sea and Ma'in recovery stays.
- Saudi Arabia generated USD 325.9 million in medical-tourism revenue in 2025.
- Medium-term potential is linked to Vision 2030, healthcare-sector investment, and the Health Sector Transformation Program's emphasis on access, quality, and private-sector participation.
- The transition from domestic capacity development to international-patient acquisition requires visible international-patient operations and a proposition that can compete with UAE and Jordanian referral models.
Egypt, Israel, Qatar, South Africa, and rest of MEA
- Egypt is formalizing its proposition through the In Egypt We Care brand and the Tour 4 Cure national platform, with a case based on access to African, Arab, and European source markets, Arabic-speaking capacity, and lower procedure costs than premium GCC destinations.
- Israel's position is driven by specialist tertiary capability in oncology, hematology, transplantation, neurology, and complex pediatric care, with Hadassah Medical Center and Sheba Medical Center operating international-patient services.
- Israel's advantage is strongest where treatment need is complex enough to justify travel, higher costs, and administrative friction, and it is less suited to volume-led elective tourism.
- Qatar is smaller but supported by high-income domestic demand, aviation connectivity, and specialist institutions; Sidra Medicine has positioned pediatric, maternal-fetal, neonatal, and rare-disease services.
- Qatar Tourism reported 5.1 million international visitors in 2025, with GCC visitors representing 36% of the total.
- South Africa is the primary medical-tourism hub for much of sub-Saharan Africa, with specialist private care, internationally trained clinicians, English-language access, and a regional cost proposition.
- Rest of MEA includes Morocco's potential in dental and cosmetic care, Lebanon's specialist private-hospital capacity, and Bahrain, Kuwait, and Oman as partial source markets for higher-acuity care in the UAE, Jordan, and Europe.
- Brevintel analysis views the UAE's USD 780.1 million 2025 position as a premium, regulated, connectivity-led model, Jordan's USD 538.9 million as referral-led, and Saudi Arabia's USD 325.9 million as the largest policy-led capacity-building opportunity.
Competitive Landscape
Structure and positioning
- Competition is fragmented across national healthcare systems and individual institutions.
- Providers compete on specialty depth, accreditation, international-patient coordination, language capability, travel access, and episode management before and after treatment.
- American Hospital Dubai led with over 6.5% market share in 2025.
- American Hospital Dubai, Cleveland Clinic Abu Dhabi, King Hussein Cancer Center, King Faisal Specialist Hospital and Research Centre, and Mediclinic Middle East collectively held 22.8% in 2025.
- Facilities that solve discharge planning, remote monitoring, and home-country clinical handoffs can build repeat-referral relationships in high-acuity corridors.
- Clinics need efficient conversion and complication pathways, whereas hospitals need referral credibility, multidisciplinary capacity, and robust cross-border discharge planning.
Destination hospital groups
- American Hospital Dubai
- Cleveland Clinic Abu Dhabi
- Mediclinic Middle East
- King Faisal Specialist Hospital and Research Centre
Specialty and tertiary centers
- King Hussein Cancer Center
- Hadassah Medical Center
- Sheba Medical Center
- Sidra Medicine